Shares of this biotech giant have lost 19.2% in the past six months against the industry’s growth of 0.6%. The stock has also ...

Detailed price information for Puretech Health Plc ADR (PRTC-Q) from The Globe and Mail including charting and trades.

In September 2025, The FDA approved an injectable extended-release risperidone suspension from Amneal Pharmaceuticals, ...

LB Pharmaceuticals, which has a schizophrenia medicine headed for late-stage testing, broke one of the longest droughts for ...

PGIM shares how the Jennison Health Sciences Fund weathered Q2 volatility by leaning into undervalued innovators. Discover ...